{"abstract": "NEW BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ \u2014 Johnson & Johnson today voluntarily disclosed to the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) that subsidiaries outside the United States are believed to have made improper payments in connection with the sale of medical devices in two small-market countries. The actions were contrary to the Company's policies, and the payments may fall within the jurisdiction of the Foreign Corrupt Practices Act. The Company will provide additional information to DOJ and SEC, and will cooperate with the agencies' reviews of these matters.", "web_url": "https://www.nytimes.com/2007/02/12/business/12jandjstatement.ready.html", "snippet": "", "lead_paragraph": "NEW BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ \u2014 Johnson & Johnson today voluntarily disclosed to the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) that subsidiaries outside the United States are believed to have made improper payments in connection with the sale of medical devices in two small-market countries. The actions were contrary to the Company's policies, and the payments may fall within the jurisdiction of the Foreign Corrupt Practices Act. The Company will provide additional information to DOJ and SEC, and will cooperate with the agencies' reviews of these matters.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson Statement on Voluntary Disclosure\n", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-02-12T16:51:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "", "person": [], "organization": null}, "type_of_material": "News", "_id": "nyt://article/83da9e1e-d338-5759-ba79-17201cdf6094", "word_count": 206, "uri": "nyt://article/83da9e1e-d338-5759-ba79-17201cdf6094"}